398098
氢碘酸
contains no stabilizer, ACS reagent, 55%
别名:
碘化氢
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
HI
化学文摘社编号:
分子量:
127.91
NACRES:
NA.21
PubChem Substance ID:
UNSPSC Code:
12352106
MDL number:
Assay:
55%, 55.0-58.0% (ACS specification)
Form:
liquid
Grade:
ACS reagent
InChI
1S/HI/h1H
SMILES string
I
InChI key
XMBWDFGMSWQBCA-UHFFFAOYSA-N
grade
ACS reagent
assay
55%, 55.0-58.0% (ACS specification)
form
liquid
does not contain
stabilizer
impurities
≤0.75% I2
ign. residue
≤0.01%
Quality Level
density
1.7 g/mL at 25 °C
anion traces
bromide, chloride (as Cl-): ≤0.05%, phosphate (PO43-): ≤0.001%, sulfate (SO42-): ≤0.005%
cation traces
Fe: ≤0.001%, heavy metals (as Pb): ≤0.001%
storage temp.
2-8°C
正在寻找类似产品? 访问 产品对比指南
General description
氢碘酸是一种强酸，是溶于水的碘化氢气体。
Application
氢碘酸通过多维气相色谱质谱法(GCxGC-qMS)用于碘化尿样，以检测芳香胺。
它可用于以下过程：
它可用于以下过程：
- 部分氟化吡啶鎓溴化物的合成过程中的脱碘过程。
- 作为氧化石墨烯纳米带(OGN)的还原剂。
- 与红磷合用，减少甲基苯丙胺合成中的伪麻黄碱。
signalword
Danger
hcodes
Hazard Classifications
Aquatic Chronic 2 - Eye Dam. 1 - Met. Corr. 1 - Skin Corr. 1B
存储类别
8B - Non-combustible corrosive hazardous materials
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
危险化学品
此项目有
Synthesis and biocompatibility evaluation of partially fluorinated pyridinium bromides.
Vyas SM, et al.
New. J. Chem., 30(6), 944-951 (2006)
Graphite oxide and graphene nanoribbons reduction with hydrogen iodide.
Cataldo F, et al.
Fullerenes, Nanotubes, and Carbon Nanostructures, 19(5), 461-468 (2011)
Patnaik P.
A Comprehensive Guide to the Hazardous Properties of Chemical Substances, 123-123 (2007)
G A Mostafa et al.
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 17(10), 1189-1193 (2002-05-07)
A simple, rapid and selective procedure for the indirect spectrophotometric determination of Se(IV) and As(V) has been developed. It is based on the reduction of Se(IV) to Se(0) and As(V) to As(III) with hydroiodic acid (KI + HCl). The liberated
Daniel J Weisenberger et al.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 24(3), 512-519 (2015-01-15)
The CpG island methylator phenotype (CIMP) represents a subset of colorectal cancers characterized by widespread aberrant DNA hypermethylation at select CpG islands. The risk factors and environmental exposures contributing to etiologic heterogeneity between CIMP and non-CIMP tumors are not known.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持